Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGF vs PRF in Revascularization of Immature Necrotic Mandibular First Permanent Molar
NCT07460869Active, not recruiting
- Sponsor
- Minia University
- Start
- Jan 2025
- Primary completion
- Jul 2026
- Modality
- Device-based Delivery, Adoptive Cell Transfer
- Countries
- 1
01
Overview
Trial of concentrated growth factor and platelet rich fibrin in pulp necrosis (2 arms), sponsored by Minia University. Primary endpoint: Root growth at 18 months. Started Jan 2025; status: active, not recruiting.
02
Drugs
concentrated growth factorplatelet rich fibrin
03
Conditions
pulp necrosis
Beyond the preview
Go deeper on NCT07460869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07460869.